Profound Medical (PROF) 6-K Current report (foreign)

Exhibit 99.2

Osler, Hoskin & Harcourt llp Box 50, 1 First Canadian Place
Toronto, Ontario, Canada  M5X 1B8
416.362.2111  main 416.862.6666  facsimile

Toronto

Montréal

Ottawa

Calgary

New York

December 5, 2024

Profound Medical Corp.

2400 Skymark Avenue, Unit #6

Mississauga, Ontario

L4W 5K5

Dear Sirs/Mesdames:

Profound Medical Corp. (the “Issuer”)

We refer you to the prospectus supplement dated December 5, 2024 to the short form base shelf prospectus of the Issuer dated July 10, 2024 filed in all provinces and territories of Canada (the “Prospectus Supplement”), forming part of the Registration Statement on Form F-10, as amended (Registration No. 333-280236) filed by the Issuer with the U.S. Securities and Exchange Commission.

We hereby consent to the references to this firm on the second cover page and under the headings “Documents Filed as Part of the Registration Statement” and “Interest of Experts” and to the reference to and use of our opinion under the heading “Eligibility For Investment” in the Prospectus Supplement.

In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder.

Yours very truly,

“Osler, Hoskin & Harcourt LLP”

Osler, Hoskin & Harcourt LLP